3De Leon A,Patel NC,Crismon ML.Aripiprazole:a comprehensive review of its pharmacology,clinical efficacy,and tolerability[J].Clin Ther,2004,26(5):649-666.
4Henderson DC,Kunkel L,Nguyen DD,et al.An exploratory openlabel trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia[J].Acta Psychiatr Scand,2006,113(2):142.
5Fleischhacker WW,Heikkinen ME,Olie JP,et al.Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine:a randomized,double-blind,placebo-controlled trial[J].Int J Neuropsychopharmacol,2010,13(8):1115-1125.
7Henderson DC,Fan X,Copeland PM,et al.Ziprasidone as an adjuvant for clozapine-or olanzapine-associated medical morbidity in chronic schizophrenia[J].Hum Psychopharmacol,2009,24(3):225-232.
8Ryan DH.Use of sibutramine and other noradrenergic andserotonergic drugs in the management of obesity[J].Endocrine,2000,13(2):193-199.
9Henderson DC,Fan X,Copeland PM,et al.A double-blind,placebo-controlled trial of sibutramine for clozapine-associated weight gain[J].Acta Psychiatr Scand,2007,115(2):101-105.
10Borovicka MC,Fuller MA,Konicki PE,et al.Phenylpropanolamine appears not to promote weight loss in patients with schizophrenia who have gained weight during clozapine treatment[J].J Clin Psychiatry,2002,63(4):345-348.
